Navigation Links
Molecular steps involved in the creation of gene-silencing microRNAs identified

First discovered only a few brief years ago, microRNAs are small, remarkably powerful molecules that appear to play a pivotal role in gene silencing, one of the body's main strategies for regulating its genome. A scant 22 nucleotides in length, miRNAs appear to work by binding to and somehow interfering with messenger RNA, itself responsible for translating genes into proteins.

But how do miRNAs arise? And what can we learn about their biological function from their origins? In a study published last year in Nature, researchers at The Wistar Institute identified a two-protein complex, called the microprocessor complex, which controls the earliest steps in the creation of miRNAs in the cell nucleus.

Now, in a new study published online by Nature today, the Wistar group has identified a three-protein complex that picks up the process in the cell cytoplasm and carries it through to the maturation of the finished miRNAs.

Taken together, the two Nature studies trace the generation of miRNAs from the genes that give rise to long primary RNA molecules through to the mature miRNAs that target messenger RNA. Significantly, the research also shows that the finished miRNAs are associated with a protein called Argonaute 2, known to be involved in inactivating messenger RNA.

"In this study, we were able to link processing of the miRNAs directly through to the molecules responsible for silencing genes," says Ramin Shiekhattar, Ph.D., an associate professor at Wistar and senior author on both Nature studies. "The miRNAs provide specificity for those molecules, which do the actual work of gene silencing."

Intriguingly, the research also links the process of creating miRNAs with aspects of the HIV life cycle and with tumor suppression. The study identifies three proteins that work together in the cytoplasm to create finished miRNAs. Individually, each of the proteins was known previously, but their joint role in producing miRNAs is newly deline ated here. Equally as important, however, is the fact that while two of the proteins had been associated with miRNAs in earlier work, the third protein, TRBP, had not been. And TRBP is clearly a protein of interest to scientists.

"TRBP was first observed as a protein that binds to HIV during transcription of the virus," says Shiekhattar. "The tantalizing implication is that the RNA interference pathway may play a significant role in HIV replication. TRBP has also been identified as a tumor suppressor, which suggests still other connections to be explored."

The lead authors on the Nature study are Thimmaiah Chendrimada, Richard I. Gregory, and Easwari Kumaraswamy, with each contributing equally to the work. The remaining co-authors are Jessica Norman, Neil Cooch, and Wistar professor Kazuko Nishikura, Ph.D. Corresponding author Shiekhattar is an associate professor in two programs at Wistar, the gene expression and regulation program and molecular and cellular oncogenesis program. Support for the research was provided by the National Institutes of Health, the American Cancer Society, and the Jane Coffin Child Memorial Fund for Medical Research.


Source:The Wistar Institute

Related biology news :

1. Molecular biology fills gaps in knowledge of bat evolution
2. Molecular machine may lead to new drugs to combat human diseases
3. Molecular Motors Cooperate In Moving Cellular Cargo, Study Shows
4. Molecular models advance the fight against malaria
5. Molecular fossils uncover link between viruses and the immune system
6. Molecular thermometers on skin cells detect heat and camphor
7. Molecular messengers perform a crucial role in the ability of injured nerve cells to heal themselves
8. Molecular miners find pain relief drugs from the sea
9. Molecular mechanism of feather formation found
10. Molecular trigger for Huntingtons disease found
11. Molecular Partners Required For Appropriate Neuronal Gene Repression
Post Your Comments:

(Date:5/12/2016)... -- , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... subsidiary of Infosys (NYSE: INFY ), and Samsung ... global partnership that will provide end customers with a ... and payment services.      (Logo: ... for financial services, but it also plays a fundamental part ...
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the ... today the Clinical Reach Virtual Patient Encounter CONSULT module which enables both ... physician and clinical trial team. , Using the CONSULT module, patients and physicians can ...
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader ... “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, ... providing practical tips, tools, and strategies for clinical researchers. , “The landscape of ...
Breaking Biology Technology: